CNBD2

Model summary

A soluble human cytosolic scaffold that uses a tandem cyclic-nucleotide–binding–like core to regulate phosphatidylcholine breakdown. It lacks intrinsic phospholipase activity and instead organizes multiprotein assemblies that execute membrane phospholipid catabolism. By coupling ligand-responsive jelly-roll folds to multivalent binding surfaces, it tunes the assembly and activity of cytosolic complexes that dismantle phosphatidylcholine during membrane remodeling and signaling.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   Two contiguous jelly-roll–type modules dominate the core of the protein: IPR014710 (PpnP-like, jelly roll fold, residues 63–224) followed immediately by IPR014710 (PpnP-like, jelly roll fold, residues 225–477). These β-sandwich scaffolds are characteristic of soluble ligand-binding domains that transmit allosteric signals rather than catalyzing chemistry. Superimposed on this scaffold are cyclic nucleotide–binding signatures: IPR018490 (Cyclic nucleotide-binding domain superfamily, residues 92–219) and IPR018490 (Cyclic nucleotide-binding domain superfamily, residues 227–471). Within these, a discrete IPR000595 (Cyclic nucleotide-binding domain, residues 116–242) and its IPR018488 conserved site (residues 143–159) define a canonical cyclic nucleotide–binding pocket. The ordered layout—an N-terminal CNB-like module followed by a second CNB-like module—creates a tandem CNB architecture that typically binds cyclic nucleotides or mimics them. Such tandem CNB arrangements cause allosteric regulation and multivalent protein interactions rather than direct enzymatic turnover.

2. 02

   This domain architecture dictates molecular function.

   The tandem CNB/jelly-roll core lacks catalytic residues for phospholipase chemistry but provides extensive surfaces for macromolecular assembly, supporting GO:0005515 protein binding as the operative molecular function. The conserved CNB site (143–159) and the paired CNB modules enable ligand- and partner-driven conformational switching, which in turn modulates assembly of lipid-metabolic complexes.

3. 03

   From function to process, the absence of catalytic motifs and the presence of interaction-centric CNB scaffolds point to regulation of lipid pathways rather than direct phosphatidylcholine hydrolysis.

   The protein’s role aligns with controlling pathways that dismantle membrane phosphatidylcholine, consistent with GO:0034638 phosphatidylcholine catabolic process. The tandem CNB platform can recruit and position enzymes and adaptors that execute phosphatidylcholine breakdown, thereby tuning membrane remodeling and signaling.

4. 04

   Cellular location follows naturally from the soluble, β-sandwich architecture and lack of transmembrane segments: the protein operates in the cytosol, matching GO:0005829 cytosol.

   A cytosolic scaffold can transiently dock to membrane-proximal assemblies without being an integral membrane component, allowing it to coordinate cytosolic phases of phosphatidylcholine turnover.

5. 05

   Mechanistically, I hypothesize that the tandem CNB domains act as an allosteric hub that senses cyclic nucleotides or related ligands to regulate assembly of phosphatidylcholine-catabolic machinery.

   By stabilizing multiprotein complexes—rather than catalyzing hydrolysis itself—the protein likely gates access of phospholipases and lipid-transfer factors to membrane substrates. Candidate partners include soluble phospholipases and cytosolic lipid-handling modules whose activities converge on phosphatidylcholine degradation. This cytosolic scaffold thus orchestrates phosphatidylcholine catabolism through regulated protein binding and assembly.